OpGen Debt to Equity Ratio 2014-2023 | OPGN
Current and historical debt to equity ratio values for OpGen (OPGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OpGen debt/equity for the three months ending September 30, 2023 was 0.00.
| OpGen Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.02B | $0.00B | 5.78 |
| 2023-06-30 | $0.02B | $0.01B | 2.27 |
| 2023-03-31 | $0.02B | $0.01B | 1.89 |
| 2022-12-31 | $0.02B | $0.01B | 2.41 |
| 2022-09-30 | $0.02B | $0.01B | 1.37 |
| 2022-06-30 | $0.02B | $0.03B | 0.78 |
| 2022-03-31 | $0.03B | $0.03B | 0.88 |
| 2021-12-31 | $0.03B | $0.04B | 0.74 |
| 2021-09-30 | $0.03B | $0.03B | 0.87 |
| 2021-06-30 | $0.03B | $0.04B | 0.73 |
| 2021-03-31 | $0.03B | $0.05B | 0.63 |
| 2020-12-31 | $0.03B | $0.02B | 1.35 |
| 2020-09-30 | $0.03B | $0.02B | 1.62 |
| 2020-06-30 | $0.03B | $0.02B | 1.47 |
| 2020-03-31 | $0.01B | $0.01B | 0.40 |
| 2019-12-31 | $0.01B | $0.00B | 1.43 |
| 2019-09-30 | $0.01B | $-0.00B | -5.13 |
| 2019-06-30 | $0.01B | $0.00B | 3.89 |
| 2019-03-31 | $0.01B | $0.00B | 1.79 |
| 2018-12-31 | $0.01B | $0.00B | 1.71 |
| 2018-09-30 | $0.01B | $0.00B | 1.29 |
| 2018-06-30 | $0.01B | $0.01B | 0.90 |
| 2018-03-31 | $0.01B | $0.01B | 0.57 |
| 2017-12-31 | $0.01B | $0.00B | 3.73 |
| 2017-09-30 | $0.01B | $0.00B | 1.45 |
| 2017-06-30 | $0.01B | $-0.00B | -3.34 |
| 2017-03-31 | $0.01B | $0.00B | 10.11 |
| 2016-12-31 | $0.01B | $0.00B | 1.84 |
| 2016-09-30 | $0.01B | $0.00B | 1.92 |
| 2016-06-30 | $0.01B | $0.01B | 0.74 |
| 2016-03-31 | $0.01B | $0.00B | 1.97 |
| 2015-12-31 | $0.01B | $0.01B | 0.84 |
| 2015-09-30 | $0.01B | $0.01B | 0.42 |
| 2015-06-30 | $0.00B | $0.01B | 0.34 |
| 2015-03-31 | $0.01B | $-0.00B | -1.65 |
| 2014-12-31 | $0.01B | $-0.00B | -1.76 |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| 2014-06-30 | $0.00B | $0.00B | 0.00 |
| 2014-03-31 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.00B | $0.00B | 18.69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.008B | $0.003B |
| OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $118.437B | 15.37 |
| Cencora (COR) | United States | $47.600B | 19.00 |
| ICON (ICLR) | Ireland | $24.090B | 23.76 |
| DiDi Global (DIDIY) | China | $22.541B | 0.00 |
| Avantor (AVTR) | United States | $16.537B | 22.78 |
| CochLear (CHEOY) | $13.442B | 0.00 | |
| Viatris (VTRS) | United States | $13.316B | 3.80 |
| Revvity (RVTY) | United States | $12.420B | 21.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
| Medpace Holdings (MEDP) | United States | $11.849B | 43.07 |
| Natera (NTRA) | United States | $10.908B | 0.00 |
| Solventum (SOLV) | United States | $10.653B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
| Doximity (DOCS) | United States | $4.699B | 34.99 |
| Organon (OGN) | United States | $4.568B | 4.42 |
| Progyny (PGNY) | United States | $3.148B | 52.82 |
| Surgery Partners (SGRY) | United States | $3.098B | 28.79 |
| Sotera Health (SHC) | United States | $3.043B | 14.93 |
| Life Times (LTH) | United States | $2.713B | 29.98 |
| GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
| Premier (PINC) | United States | $2.473B | 9.05 |
| Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
| Agilon Health (AGL) | United States | $2.052B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
| Agiliti (AGTI) | United States | $1.365B | 22.29 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.590B | 3.89 |
| Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.18 |
| MultiPlan (MPLN) | United States | $0.467B | 0.00 |
| CareDx (CDNA) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.409B | 0.00 |
| LifeMD (LFMD) | United States | $0.398B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 56.00 |
| Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
| ModivCare (MODV) | United States | $0.295B | 3.91 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
| Sharecare (SHCR) | United States | $0.237B | 0.00 |
| Biodesix (BDSX) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.087B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |